VANGUARD GROUP INC

Holdings History for Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL)

Symbol: CADL on Nasdaq
Investment type: Equity / Common stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	0%	+0%	$10,236,272	2,007,112	+219,563	+12%	$5.10	Q3 2025
30 Jun 2025	0%	+0%	$9,044,999	1,787,549	+51,445	+3%	$5.06	Q2 2025
31 Mar 2025	0%	+0%	$9,808,988	1,736,104	+396,954		$5.65	Q1 2025
31 Dec 2024	0%	+0%	$11,623,822	1,339,150	+392,885	+42%	$8.68	Q4 2024
30 Sep 2024	0%	+0%	$6,557,616	946,265	+127,715	+16%	$6.93	Q3 2024
30 Jun 2024	0%	+0%	$5,075,010	818,550	+277,255	+51%	$6.20	Q2 2024
31 Mar 2024	0%	+0%	$855,246	541,295	+115,546	+27%	$1.58	Q1 2024
31 Dec 2023	0%	+0%	$625,851	425,749	+21,680	+5.4%	$1.47	Q4 2023
30 Sep 2023	0%	0%	$371,743	404,069	-1,686	-0.42%	$0.9200	Q3 2023
30 Jun 2023	0%	0%	$511,251	405,755	0		$1.26	Q2 2023
31 Mar 2023	0%	0%	$547,769	405,755	0		$1.35	Q1 2023
31 Dec 2022	0%	0%	$726,302	405,755	+294	+0.07%	$1.79	Q4 2022
30 Sep 2022	0%	0%	$1,273,000	405,461	0		$3.14	Q3 2022
30 Jun 2022	0%	0%	$1,313,000	405,461	-1,695	-0.42%	$3.24	Q2 2022
31 Mar 2022	0%	-0%	$2,073,000	407,156	-8,197	-2%	$5.09	Q1 2022
31 Dec 2021	0%	+0%	$3,248,000	415,353	+201,773	+94%	$7.82	Q4 2021
30 Sep 2021	0%	+0%	$2,315,000	213,580	+213,580	NEW	$10.84	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.